Skip to main content
. 2019 Oct 15;55:81–88. doi: 10.29390/cjrt-2019-011

TABLE 1. Characteristics of patients.

Variable All patients
Pre-term ≤32 6/7 weeks, intubated at day-of-life 1
Group 1 (n = 294) Group 2 (n = 295) p Group 1 (n = 46) Group 2 (n = 38) p
Female, n (%) 126 (42.9) 115 (39.3) 0.37 20 (43.5) 13 (34.2) 0.39
Gestational age,a weeks (mean (SD)) 34.7 (5.0) 35.2 (4.6) 0.40 28.3 (2.7) 28.8 (2.4) 0.38
Birthweight, kg (mean (SD)) 2.4 (1.1) 2.5 (0.99) 0.52 1.2 (0.50 1.2 (0.4) 0.72
Weight at extubation, kg (mean (SD)) 2.6 (1.1) 2.7 (0.99) 0.38 1.4 (0.6) 1.3 (0.4) 0.88
FiO2 prior extubation (mean (SD)) 0.23 (0.1) 0.23 (0.1) 0.14 0.27 (0.1) 0.23 (0.1) 0.17
Received antenatal steroids, n (%) 21 (46.7) 21 (56.8) 0.36
Received Surfactant, n (%) 38 (82.6) 24 (63.2) 0.04
All grade IVH, n (%) 13 (28.2) 13 (34.2) 0.99
Post-extubation supportb
 Room air 160 (54.4) 170 (57.6) 6 (13.0) 10 (26.3)
 CPAP 59 (20.1) 79 (26.8) 24 (52.2) 18 (47.4)
 Biphasic CPAP 5 (2.5) 0 2 (4.4) 0
 LFNC 40 (13.6) 14 (4.8) 1 (2.2) 1 (2.6)
 HFNC 6 (2.0) 2 (0.7) 0 0
 NIPPV 20 (6.8) 28 (9.5) 10 (21.7) 8 (21.1)
 NI-HFOV 3 (1.0) 1 (0.3) 0 0
 Oxyhood 1 (0.3) 1 (0.3) 0 0
Main diagnosis category
 Respiratory 48 (16.3) 44 (14.9)
 Infectious 9 (3) 6 (2)
 Cardiac 7 (3.1) 5 (1.7)
 Neurologic 41 (13.9) 58 (19.7)
 Genetic/metabolic 10 (3.4) 12 (4.1)
 Surgical 61 (20.7) 64 (21.7)
 Prematurity and related complications 118 (40.1) 106 (35.9)
Length of stay, days (Median (range)) 13 (1–199) 11 (2–221) 0.29 32 (3–199) 23 (3–123) 0.30
a

n = 2 missing from Group 1.

b

unable to run Chi-Square test because of low cell count.

Note: CPAP, continuous positive airway pressure; FiO2, fractional inspiratory oxygen; HFNC, high-flow nasal cannula; IVH, intraventicular hemorrhage; LFNC, low-flow nasal cannula; NI-HFOV, noninvasive high-flow oscillatory ventilation; NIPPV, noninvasive positive pressure ventilation.